Docoh
Loading...

NMRD Nemaura Medical

News

From Benzinga Pro
Nemaura Medical Launches Metabolic Health Program For Employers, Insurers
13 Jan 22
News
Nemaura Medical, Inc. (NASDAQ:NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting
Nemaura Medical Names Arash Ghadar As COO
10 Jan 22
News, Management
Nemaura Medical, Inc. (NASDAQ:NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting
54 Biggest Movers From Yesterday
8 Dec 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021
2 Dec 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
EF Hutton Initiates Coverage On Nemaura Medical with Buy Rating, Announces Price Target of $7.5
2 Dec 21
News, Price Target, Initiation, Analyst Ratings
EF Hutton analyst Constantine Davides initiates coverage on Nemaura Medical (NASDAQ:NMRD) with a Buy rating and announces Price Target of $7.5.
Nemaura Medical Q2 EPS $(0.15) Misses $(0.11) Estimate
15 Nov 21
Earnings, News
Nemaura Medical (NASDAQ:NMRD) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.11) by 36.36 percent. This is a 114.29 percent decrease over losses of $(0.07) per share